As of 2024-12-14, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 8.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 56.56 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -84.6%.
The range of the Relative Valuation is 2.85 - 19.15 USD.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 6.2x | 5.8x |
| Forward P/E multiples | 8.5x - 17.1x | 12.8x |
| Fair Price | 2.85 - 19.15 | 8.72 |
| Upside | -95.0% - -66.1% | -84.6% |
| Date | P/E |
| 2024-12-12 | 106.95 |
| 2024-12-11 | 111.89 |
| 2024-12-10 | 111.87 |
| 2024-12-09 | 109.73 |
| 2024-12-06 | 107.73 |
| 2024-12-05 | 105.88 |
| 2024-12-04 | 107.52 |
| 2024-12-03 | 107.54 |
| 2024-12-02 | 109.43 |
| 2024-11-29 | 108.22 |
| 2024-11-27 | 112.30 |
| 2024-11-26 | 109.41 |
| 2024-11-25 | 110.89 |
| 2024-11-22 | 107.61 |
| 2024-11-21 | 105.63 |
| 2024-11-20 | 104.19 |
| 2024-11-19 | 105.31 |
| 2024-11-18 | 104.48 |
| 2024-11-15 | 106.99 |
| 2024-11-14 | 111.40 |
| 2024-11-13 | 113.14 |
| 2024-11-12 | 115.35 |
| 2024-11-11 | 116.75 |
| 2024-11-08 | 116.18 |
| 2024-11-07 | 110.39 |
| 2024-11-06 | 110.43 |
| 2024-11-05 | 108.37 |
| 2024-11-04 | 105.91 |
| 2024-11-01 | 110.04 |
| 2024-10-31 | 108.25 |
| 2024-10-30 | 110.64 |
| 2024-10-29 | 111.59 |
| 2024-10-28 | 109.61 |
| 2024-10-25 | 110.28 |
| 2024-10-24 | 112.10 |
| 2024-10-23 | 111.64 |
| 2024-10-22 | 113.61 |
| 2024-10-21 | 112.10 |
| 2024-10-18 | 114.04 |
| 2024-10-17 | 113.68 |
| 2024-10-16 | 112.82 |
| 2024-10-15 | 110.81 |
| 2024-10-14 | 110.62 |
| 2024-10-11 | 108.05 |
| 2024-10-10 | 104.19 |
| 2024-10-09 | 107.27 |
| 2024-10-08 | 107.39 |
| 2024-10-07 | 105.59 |
| 2024-10-04 | 109.35 |
| 2024-10-03 | 107.39 |